Long-range gene regulation is crucial for proper gene expression and is often disrupted in disease. Regulatory elements, including enhancers and repressors, can be located far from the transcription unit and are essential for spatiotemporal and quantitative control of gene expression. These elements are often conserved and can be affected by chromosomal rearrangements, leading to disease. For example, in aniridia, mutations in the PAX6 gene are often due to chromosomal rearrangements that disrupt regulatory elements downstream of the gene. Similarly, mutations in the POU3F4 gene cause X-linked deafness, and regulatory elements upstream of the gene are involved in its expression. Other diseases, such as facioscapulohumeral dystrophy (FSHD), are linked to chromosomal deletions that affect regulatory elements, leading to gene dysregulation. The zinc finger gene GLI3 is involved in embryonic development and mutations can cause Greig cephalopolysyndactyly syndrome. The MAF gene is involved in lens development, and mutations can cause lens and iris anomalies. Forkhead genes, such as FOXC1 and FOXC2, are involved in eye development and mutations can cause ocular malformations. The SOX9 gene is involved in sex determination and limb development, and mutations can cause campomelic dysplasia. The SHH gene is involved in limb development and mutations can cause limb abnormalities. The ZRS element, located 1 Mb upstream of the SHH gene, is a regulatory element that controls SHH expression. The SHFM1 gene is involved in limb development and mutations can cause split-hand/split-foot malformation. The D4Z4 repeats on chromosome 4 are involved in FSHD, and their deletion leads to gene dysregulation. The α-thalassemia case involves antisense RNA that silences the HBA2 gene. These examples highlight the importance of long-range regulatory elements in gene expression and disease. Animal models have been used to study these mechanisms, providing insights into the role of regulatory elements in gene expression and disease.Long-range gene regulation is crucial for proper gene expression and is often disrupted in disease. Regulatory elements, including enhancers and repressors, can be located far from the transcription unit and are essential for spatiotemporal and quantitative control of gene expression. These elements are often conserved and can be affected by chromosomal rearrangements, leading to disease. For example, in aniridia, mutations in the PAX6 gene are often due to chromosomal rearrangements that disrupt regulatory elements downstream of the gene. Similarly, mutations in the POU3F4 gene cause X-linked deafness, and regulatory elements upstream of the gene are involved in its expression. Other diseases, such as facioscapulohumeral dystrophy (FSHD), are linked to chromosomal deletions that affect regulatory elements, leading to gene dysregulation. The zinc finger gene GLI3 is involved in embryonic development and mutations can cause Greig cephalopolysyndactyly syndrome. The MAF gene is involved in lens development, and mutations can cause lens and iris anomalies. Forkhead genes, such as FOXC1 and FOXC2, are involved in eye development and mutations can cause ocular malformations. The SOX9 gene is involved in sex determination and limb development, and mutations can cause campomelic dysplasia. The SHH gene is involved in limb development and mutations can cause limb abnormalities. The ZRS element, located 1 Mb upstream of the SHH gene, is a regulatory element that controls SHH expression. The SHFM1 gene is involved in limb development and mutations can cause split-hand/split-foot malformation. The D4Z4 repeats on chromosome 4 are involved in FSHD, and their deletion leads to gene dysregulation. The α-thalassemia case involves antisense RNA that silences the HBA2 gene. These examples highlight the importance of long-range regulatory elements in gene expression and disease. Animal models have been used to study these mechanisms, providing insights into the role of regulatory elements in gene expression and disease.